Videos & Visuals
Kevin M. Alexander, MD, eagerly awaits the presentation of new amyloid dataat the 2026 ACC meeting in New Orleans and is especially interested in the subgroup…
Welcome back to another AJMC Payer Perspectives series. In this opening episode titled, ‘Transthyretin Amyloid Cardiomyopathy (ATTR-CM): Clinical Burden and…
Long-term survival benefits were seen in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) using the drug acoramidis (Attruby) in new data presented at…
In 2015, Jack started to have shortness of breath. It wouldn't go away and became impossible to ignore.
In this special session, Dr. Barry Trachtenberg and members of the ATTR amyloidosis community came together to share medical insights and lived experiences related…
The rising prevalence of several associated risk factors, including genetic mutations, chronic inflammation or infection, overproduction of specific proteins, etc…
By Kathy FeistMike Lane is trying to get the word out to the Black community: If you are over the age of 60, feeling fatigue and tingling in your extremities, have…
Cardiomyopathy is a broad term that is used to describe disease of the heart muscle, making it difficult for the heart to provide the body with an adequate blood…